Next Article in Journal
Synthesis of a New Bioconjugate Steroid Pyridinium Salt Derived from Allopregnanolone Acetate
Previous Article in Journal
4-(1,3-Dioxoisoindolin-2-yl)butyl(2R,4aS,6aS,12bR,14aS,14bR)-10-hydroxy-2,4a,6a,9,12b,14a-hexamethyl-11-oxo-1,2,3,4,4a,5,6,6a,11,12b,13,14,14a,14b-tetradecahydropicene-2-carboxylate
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Short Note

5-[2-(4-Chlorophenyl)-2-oxoethyl]-3-(4-hydroxyphenyl)-2-thioxo-1,3-thiazolidin-4-one

Department of Organic Chemistry, Faculty of Pharmacy, Medical University of Lublin, 4A Chodzki Street, 20-093 Lublin, Poland
Molbank 2025, 2025(3), M2049; https://doi.org/10.3390/M2049
Submission received: 23 July 2025 / Revised: 14 August 2025 / Accepted: 18 August 2025 / Published: 20 August 2025

Abstract

Rhodanine derivatives, as a subtype of thiazolidin-4-ones, represent an important class of heterocyclic compound known for their broad spectrum of biological activities and practical applications. In this short note, the synthesis of a new compound, 5-[2-(4-chlorophenyl)-2-oxoethyl]-3-(4-hydroxyphenyl)-2-thioxo-1,3-thiazolidin-4-one, is described. The target molecule was synthesized via a thia-Michael addition followed by cyclocondensation. Its structure was confirmed by 1H and 13C NMR spectroscopy and further supported by 2D NMR studies.

1. Introduction

In recent years, heterocyclic compounds have attracted considerable attention due to their remarkable structural diversity and broad spectrum of biological activities. Among these, rhodanine derivatives stand out as a particularly important subclass of thiazolidin-4-ones, well known for their promising pharmacological potential and versatile synthetic applications [1,2,3]. Their chemical scaffold enables the design of molecules with diverse biological properties, making them valuable candidates for the development of new antimicrobial [4,5], antiviral [6,7], anticancer [8,9], and anti-inflammatory [10,11] agents. Beyond their therapeutic significance, rhodanine-based compounds are also widely used as intermediates in organic synthesis and as key building blocks for advanced materials, dyes, and sensors [12,13].
Motivated by the ongoing search for new bioactive molecules, this short note describes the synthesis of a novel 5-[2-(4-chlorophenyl)-2-oxoethyl]-3-(4-hydroxyphenyl)-2-thioxo-1,3-thiazolidin-4-one, which may serve as a promising candidate for further biological studies.

2. Results and Discussion

The target, compound 3, was obtained through two-step synthesis (Scheme 1) [14]. In the first step, 4-aminophenol (1) was reacted with carbon disulfide in the presence of triethylamine, leading to the formation of triethylammonium (4-hydroxyphenyl)dithiocarbamate (2). In the second step, compound 2 underwent a thia-Michael addition with 3-(4-chlorobenzoyl)acrylic acid, followed by cyclocondensation of the resulting intermediate, to yield the target compound, 5-[2-(4-chlorophenyl)-2-oxoethyl]-3-(4-hydroxyphenyl)-2-thioxo-1,3-thiazolidin-4-one (3).
The structure of the target, compound 3, was elucidated through elemental analysis, FT-IR, and 1H and 13C NMR spectroscopy, and supported by 2D NMR experiments (COSY, NOESY, HSQC, and HMBC), which were instrumental in assigning key signals.
The chemical shifts in proton signals derived from para-substituted phenyl moieties were presented as two doublets at 6.89 and 7.08 ppm for the 4-hydroxyphenyl fragment, and 7.64 and 8.01 ppm for the 4-chlorophenyl substituent with coupling constants (J) 8.8 and 8.7 Hz, respectively. Furthermore, compound 3 contains diastereotopic protons of the methylene group. This fragment is presented in 1H NMR as an ABX spin system (CHAHBCHX), which appears as three doublets of doublets at 4.01, 4.18, and 4.96 ppm. The values of coupling constants were 3.5, 8.4, and 19.0 Hz for JAB, JAX, and JBX, respectively. The high value of JBX agreed with the data from Takahashi (“carbonyl effect”) for the structurally related 2-thioxo-4-oxothiazolidine-5-acetic acid [15].
The 13C NMR spectrum of compound 3 confirmed the presence of all carbon atoms in the molecule. It exhibited a characteristic signal for the C=S group at 204.2 ppm. The signals of the two C=O groups were observed at 176.8 ppm for the carbonyl of the thiazolidine ring and at 196.5 ppm for the carbonyl of the 4-chlorobenzoyl moiety. The signals from the aliphatic fragment of the molecule appeared at 41.1 ppm (CH2) and 46.5 ppm (CH). All aromatic carbons were observed in the range of 116.2–158.5 ppm. The HMBC experiment shown in Figure 1 presented long-range correlations between protons and carbon atoms (13C).
The detailed data from the 1H and 13C NMR, DEPT-135, and 2D NMR experiments (COSY, NOESY, HSQC, and HMBC) are presented in the Materials and Methods Section and the Supplementary Materials (Figures S1–S7).
The IR spectral analysis of compound 3 confirms two distinct carbonyl stretching vibrations at 1731 and 1668 cm−1, corresponding to the carbonyl groups in the thiazolidine ring and next to the 4-chlorophenyl moiety. Also observed was an absorption band at 1157 cm−1, corresponding to the C=S group. The detailed FT-IR absorption bands are presented in the Supplementary Materials (Figure S8).

3. Materials and Methods

3.1. General

All commercial reagents and solvents were purchased from Merck Co. (Darmstadt, Germany) or Fisher Scientific (Waltham, MA, USA) and used without further purification. The melting point was determined using an Electrothermal Standard 120 VAC apparatus (Cole-Parmer, Wertheim, Germany) and was uncorrected. The 1H NMR and 13C NMR spectra and DEPT-135 and 2D NMR experiments were recorded by a Bruker Avance DPX 600 (Billerica, MA, USA) using DMSO-d6 as solvent and TMS as an internal standard. Chemical shifts were expressed as δ (ppm). Multiplicities are reported, using the standard abbreviations, as follows: singlet (s), doublet (d), doublet of doublets (dd). The FT-IR spectrum was recorded with a Nicolet 6700 spectrometer (Thermo Scientific, Philadelphia, PA, USA). Elemental analysis was performed with an AMZ 851 CHX analyser (PG, Gdansk, Poland) and the results were within ±0.4% of the theoretical value.

3.2. Synthesis of Triethylammonium (4-hydroxyphenyl)dithiocarbamate (2)

The synthesis of triethylammonium (4-hydroxyphenyl)dithiocarbamate (compound 2) was performed according to a previously described method [16,17]. The physicochemical data were consistent with those reported in the patents [16,17].

3.3. Synthesis of 5-[2-(4-Chlorophenyl)-2-oxoethyl]-3-(4-hydroxyphenyl)-2-thioxo-1,3-thiazolidin-4-one (3)

To a solution of 0.005 mol (1.43 g) of triethylammonium (4-hydroxyphenyl)dithiocarbamate in 10 mL of ethanol, a solution of 0.005 mol (1.05 g) of 3-(4-chlorobenzoyl)acrylic acid in ethanol (10 mL) was added. The reaction mixture was stirred at room temperature for 30 min. Then, the reaction mixture was acidified with 3 mL of concentrated HCl. The product was precipitated by pouring the mixture into 100 mL of water. The resulting precipitate was filtered and recrystallized from methanol.
Yield 74%, m.p. = 200–201 °C. FT-IR (ν, cm−1): 1731, 1668 (C=O), 1589 (C=C), 1348 (C-N), 1212 (Car-OH), 1157 (C=S), 806 (C-S).
1H NMR (600 MHz, DMSO-d6) δ (ppm): 4.01 dd (1H, CH-CH2, J = 8.4, 19.0 Hz); 4.18 dd (1H, CH-CH2, J = 3.5, 19.0 Hz); 4.96 dd (1H, CH-CH2, J = 3.5, 8.4 Hz); 6.89 d, 7.08 d (4H, 4-OH-C6H4, J = 8.8 Hz); 7.64 d, 8.01 d (4H, 4-Cl-C6H4, J = 8.7 Hz); 9.85 s (1H, OH). 13C NMR (150 MHz, DMSO-d6) δ (ppm): 41.1 (CH2), 46.5 (CH), 116.2 (2Car.), 127.1 (Car.-N), 129.5 (2Car.), 130.1 (2Car.), 130.6 (2Car.), 134.6 (Car.-CO), 139.4 (Car.-Cl), 158.5 (Car.-OH), 176.8 (C=O, thiazolidine), 196.5 (C=O), 204.2 (C=S). Anal. calc. for C17H12ClNO3S2 (377.865) (%): C 54.04, H 3.20, N 3.71. Found: C 54.07, H 3.17, N 3.65.

4. Conclusions

As a result of the current research, a new rhodanine derivative 3, namely, 5-[2-(4-chlorophenyl)-2-oxoethyl]-3-(4-hydroxyphenyl)-2-thioxo-1,3-thiazolidin-4-one, has been synthesized. The compound was obtained at a good yield via a thia-Michael addition reaction followed by intramolecular cyclocondensation, starting from triethylammonium (4-hydroxyphenyl)dithiocarbamate.

Supplementary Materials

The following supporting information can be downloaded at Figure S1: 1H NMR spectrum of compound 3; Figure S2: 13C NMR spectrum of compound 3; Figure S3: DEPT-135 spectrum of compound 3; Figure S4: COSY spectrum of compound 3; Figure S5: NOESY spectrum of compound 3; Figure S6: HSQC spectrum of compound 3; Figure S7: HMBC spectrum of compound 3; Figure S8: FT-IR spectrum of compound 3.

Funding

This research received no external funding.

Data Availability Statement

The data are contained within the article and Supplementary Materials.

Conflicts of Interest

The author declares no conflicts of interest.

References

  1. Kaminskyy, D.; Kryshchyshyn, A.; Lesyk, R. Recent developments with rhodanine as a scaffold for drug discovery. Expert Opin. Drug Discov. 2017, 12, 1233–1252. [Google Scholar] [CrossRef] [PubMed]
  2. Chaurasyia, A.; Chawla, P.; Monga, V.; Singh, G. Rhodanine derivatives: An insight into the synthetic and medicinal perspectives as antimicrobial and antiviral agents. Chem. Biol. Drug Des. 2023, 101, 500–549. [Google Scholar] [CrossRef] [PubMed]
  3. Szczepański, J.; Tuszewska, H.; Trotsko, N. Anticancer profile of rhodanines: Structure–Activity Relationship (SAR) and molecular targets—A review. Molecules 2022, 27, 3750. [Google Scholar] [CrossRef] [PubMed]
  4. Abusetta, A.; Alumairi, J.; Alkaabi, M.Y.; Al Ajeil, R.; Shkaidim, A.A.; Akram, D.; Pajak, J.; Ghattas, M.; Atatreh, N.; Al Neyadi, S.S. Design, synthesis, in vitro antibacterial activity, and docking studies of new rhodanine derivatives. Open J. Med. Chem. 2020, 10, 15–34. [Google Scholar] [CrossRef]
  5. Horishny, V.; Kartsev, V.; Geronikaki, A.; Matiychuk, V.; Petrou, A.; Glamoclija, J.; Petrou, A.; Sokovic, M. 5-(1H-Indol-3-ylmethylene)-4-oxo-2-thioxothiazolidin-3-ylalkancarboxylic acids as antimicrobial agents: Synthesis, biological evaluation, and molecular docking studies. Molecules 2020, 25, 1964. [Google Scholar] [CrossRef] [PubMed]
  6. Gentili, V.; Turrin, G.; Marchetti, P.; Rizzo, S.; Schiuma, G.; Beltrami, S.; Cristofori, V.; Illuminati, D.; Comapnin, V.; Trapella, C.; et al. Synthesis and biological evaluation of novel rhodanine-based structures with antiviral activity toward HHV-6 virus. Bioorg. Chem. 2022, 119, 105518. [Google Scholar] [CrossRef] [PubMed]
  7. Pu, J.; He, X.; Xu, W.; Wang, C.; Lan, Q.; Hua, C.; Wang, K.; Lu, L.; Jiang, S. The analogs of furanyl methylidene rhodanine exhibit broad-spectrum inhibitory and inactivating activities against enveloped viruses, including SARS-CoV-2 and its variants. Viruses 2022, 14, 489. [Google Scholar] [CrossRef] [PubMed]
  8. Szczepański, J.; Khylyuk, D.; Korga-Plewko, A.; Michalczuk, M.; Mańdziuk, S.; Iwan, M.; Trotsko, N. Rhodanine–piperazine hybrids as potential VEGFR, EGFR, and HER2 targeting anti-breast cancer agents. Int. J. Mol. Sci. 2024, 25, 12401. [Google Scholar] [CrossRef] [PubMed]
  9. Buzun, K.; Kryshchyshyn-Dylevych, A.; Senkiv, J.; Roman, O.; Gzella, A.; Bielawski, K.; Bielawska, A.; Lesyk, R. Synthesis and anticancer activity evaluation of 5-[2-chloro-3- (4-nitrophenyl)-2-propenylidene]-4-thiazolidinones. Molecules 2021, 26, 3057. [Google Scholar] [CrossRef] [PubMed]
  10. Zhu, L.; Ye, C.; Chen, S.; Fang, Y.; Zhang, Y.; Zhang, T. Rhodanine derivatives containing 5-aryloxypyrazole moiety as anti-inflammatory and anticancer agents. Chem. Biodiversity 2024, 21, e202301844. [Google Scholar] [CrossRef] [PubMed]
  11. Kwak, J.-S.; Lee, Y.; Yang, J.; Kim, S.K.; Shin, Y.; Kim, H.-J.; Choi, J.H.; Im, Y.J.; Kim, M.-J.; Lee Yu, K.; et al. Characterization of rhodanine derivatives as potential disease-modifying drugs for experimental mouse osteoarthritis. Osteoarthr. Cartil. 2022, 30, 1210–1221. [Google Scholar] [CrossRef] [PubMed]
  12. Li, R.; Xie, L.; Feng, H.; Liu, B. Molecular engineering of rhodamine dyes for highly efficient D-π-A organic sensitizer. Dyes Pigm. 2018, 156, 53–60. [Google Scholar] [CrossRef]
  13. Syiemlieh, C.C.; Ilango, B.; Kothandaraman, R.; Venkatakrishnan, P.; Velusamy, M.; Kathiravan, A. Delving into the role of a conjugated rhodanine acceptor in D–D′–A dyes for photovoltaic applications. J. Phys. Chem. C 2025, 129, 5821–5832. [Google Scholar] [CrossRef]
  14. Omar, M.T.; Kandeel, K.A.; Youssef, A.S.A. The (E)/(Z)-ratio in the reaction of 5-(2-aryl-2-oxoethyl)-2-thioxo-4-oxo-1,3-thiazolidines with bromine. Monatsh. Chem. 1995, 126, 439–446. [Google Scholar] [CrossRef]
  15. Takahashi, T. Spin-spin coupling constants for methylene groups adjacent to carbonyl groups. Tetrahedron Lett. 1964, 5, 565–572. [Google Scholar] [CrossRef]
  16. Brand, W.W.; Lovell, J.B. Insect control compounds. U.S. Patent 4,004,019, 18 January 1977. [Google Scholar]
  17. Hall, B.; Praveen, K.; Decorte, B. Nifuroxazide analogs and therapeutic uses thereof. WO 2019/126568 A1, 27 June 2019. [Google Scholar]
Scheme 1. Synthetic route for target compound 3. Reagents and conditions: (i) CS2, Et3N, stirred at rt; (ii) 3-(4-chlorobenzoyl)acrylic acid, stirred at rt for 30 min; HCl conc.
Scheme 1. Synthetic route for target compound 3. Reagents and conditions: (i) CS2, Et3N, stirred at rt; (ii) 3-(4-chlorobenzoyl)acrylic acid, stirred at rt for 30 min; HCl conc.
Molbank 2025 m2049 sch001
Figure 1. Some 1H and 13C NMR shifts of compound 3 with key interactions in the relevant HMBC and COSY spectra.
Figure 1. Some 1H and 13C NMR shifts of compound 3 with key interactions in the relevant HMBC and COSY spectra.
Molbank 2025 m2049 g001
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Trotsko, N. 5-[2-(4-Chlorophenyl)-2-oxoethyl]-3-(4-hydroxyphenyl)-2-thioxo-1,3-thiazolidin-4-one. Molbank 2025, 2025, M2049. https://doi.org/10.3390/M2049

AMA Style

Trotsko N. 5-[2-(4-Chlorophenyl)-2-oxoethyl]-3-(4-hydroxyphenyl)-2-thioxo-1,3-thiazolidin-4-one. Molbank. 2025; 2025(3):M2049. https://doi.org/10.3390/M2049

Chicago/Turabian Style

Trotsko, Nazar. 2025. "5-[2-(4-Chlorophenyl)-2-oxoethyl]-3-(4-hydroxyphenyl)-2-thioxo-1,3-thiazolidin-4-one" Molbank 2025, no. 3: M2049. https://doi.org/10.3390/M2049

APA Style

Trotsko, N. (2025). 5-[2-(4-Chlorophenyl)-2-oxoethyl]-3-(4-hydroxyphenyl)-2-thioxo-1,3-thiazolidin-4-one. Molbank, 2025(3), M2049. https://doi.org/10.3390/M2049

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop